RecruitingNot ApplicableNCT07335146

Eye Imaging for the Study of Childhood Myopia

Modélisation de l'œil Myope Infantile Par IRM et OCT


Sponsor

Essilor International

Enrollment

100 participants

Start Date

Feb 18, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Myopia (nearsightedness) is increasing worldwide and is becoming a serious public health problem. Studies estimate that by 2050, if no action is taken, almost half of the world's population will be myopic. About 10% of people could develop severe myopia, which increases the risk of serious eye problems such as retinal detachment, damage to the macula, or glaucoma. Children are particularly affected because myopia often worsens as they grow. Several treatments are now available to slow the progression of myopia in children, but these treatments are not equally effective for everyone. Some children respond better than others, and the reasons for these differences are not yet well understood. One possible explanation is that differences in eye anatomy may influence the effectiveness of a treatment. This suggests that myopia treatments may need to be tailored to each child. By studying the anatomy of the eye, researchers could improve and personalize myopia control strategies. The study entitled "Eye imaging for the study of childhood myopia" aims to better understand the structure of children's eyes. The study will collect clinical data, including images of the eye taken with MRI and measurements of the eye obtained using standard eye examination devices. The data will then be analyzed using image-processing and statistical methods to allow a detailed study of children's eye anatomy.


Eligibility

Min Age: 6 YearsMax Age: 12 Years

Inclusion Criteria3

  • Spherical equivalent under cycloplegia greater -6.5 D and less than 2 D
  • Beneficiary of social security
  • Written consent from both holders of parental authority (or from one in case of exclusive parental authority)

Exclusion Criteria5

  • Declared neurological deficit, including history of epileptic pathology or sensory-motor coordination disorders, vestibular or cerebellar pathology (for example, balance disorders)
  • Current or progressive pathology of the eyes or their appendages that may affect vision, other than myopia (examples: glaucoma, retinitis pigmentosa…)
  • Declared aphakia or pseudophakia (intraocular implant)
  • Ocular motility problem such as strabismus or nystagmus
  • Contraindication to MRI (claustrophobia, implanted devices such as pacemaker, etc.)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOphtalmic measurements to estimate geometrical distances

Patients will undergo routine ophthalmic examinations, such as ocular biometry to estimate axial length and corneal topography. Anatomical characteristics will then be derived from the geometric measurements obtained from each device. All measurements are non-invasive and non-ionizing. They all involve conventional ophthalmic devices that are widely used in clinical settings.

DEVICEMRI

Participants will undergo Magnetic Resonance Imaging (MRI) to image their eyes. A head antenna will be used. All measurements are non-invasive.

DEVICEOphtalmic measurements to measure wavefront aberrations

Patients will undergo ophthalmic measurements to assess ocular wavefront aberrations. These measurements will be performed using commercially available devices that are widely accepted in routine clinical practice. All procedures are non-invasive and non-ionizing.


Locations(1)

Hôpital Fondation Adolphe de Rothschild

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07335146


Related Trials